XML 41 R25.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stockholders' Equity (Tables)
12 Months Ended
Jan. 31, 2017
Equity [Abstract]  
Summary of Option Activity

The following is a summary of the Company’s option activity:

 

    Options     Weighted
Average  Exercise Price
 
             
Outstanding – January 31, 2015     496,404     $ 1.04  
Exercisable – January 31, 2015     496,404     $ 1.04  
Granted     -     $ -  
Exercised     -     $ -  
Forfeited/Cancelled     -     $ -  
Outstanding – January 31, 2016     496,404     $ 1.04  
Exercisable – January 31, 2016     496,404     $ 1.04  
Granted     385,000     $ 0.46  
Exercised     -     $ -  
Forfeited/Cancelled     -     $ -  
Outstanding – January 31, 2017     881,404     $ 0.78  
Exercisable – January 31, 2017     799,404     $ 0.78

Summary of Option Outstanding and Exercisable

Options Outstanding   Options Exercisable  
Exercise Price     Number Outstanding     Weighted Average Remaining Contractual Life (in years)     Weighted Average Exercise Price       Number Exercisable       Weighted Average Exercise Price  
                                     
0.39 – 2.97     881,404     2.26 years   $ 0.78       799,404     $ 0.78

Schedule of Warrants Activity

The following is a summary of the Company’s warrant activity:

 

    Warrants     Weighted  Average  Exercise Price  
             
Outstanding – January 31, 2015     1,027,401     $ 1.27  
Exercisable – January 31, 2015     1,027,401     $ 1.27  
Granted     3,797,035     $ 0.68  
Exercised     (22,666 )   $ 1.25  
Forfeited/Cancelled     -     $ -  
Outstanding – January 31, 2016     4,801,770     $ 0.80  
Exercisable – January 31, 2016     4,801,770     $ 0.80  
Granted     2,510,000     $ 1.50  
Exercised     -     $ -  
Forfeited/Cancelled     -     $ -  
Outstanding – January 31, 2017     7,311,770     $ 1.04  
Exercisable – January 31, 2017     7,311,770     $ 1.04

Schedule of Warrants Outstanding and Exercisable

  Warrants Outstanding   Warrants Exercisable
  Range of  Exercise Price     Number Outstanding     Weighted Average Remaining Contractual Life (in years)     Weighted Average Exercise Price     Number Exercisable     Weighted Average Exercise Price  
                                   
$ 0.68-$2.50     7,311,770     3.49 years   $ 1.04     7,311,770   $ 1.04

Schedule of Fair Value of Warrants Granted

For the year ended January 31, 2017, when computing fair value of the warrants granted, the Company has considered the following variables:

 

    January 31, 2017  
Risk-free interest rate     1.28 %
Expected life of grants     5 years  
Expected volatility of underlying stock     155 %
Dividends     0 %